{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:02:27Z","timestamp":1770987747644,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04167-9","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:33:49Z","timestamp":1768919629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary miR-191-5p levels are significantly reduced after radical prostatectomy in patients with prostate cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Fatima Domenica Elisa","family":"De Palma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Carbonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Cernera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Gelzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Nardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savio Domenico","family":"Pandolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille","family":"Aveta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisto","family":"Perdon\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"4167_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. Prostate cancer. Nat Rev Dis Primers. 2021;7:9. https:\/\/doi.org\/10.1038\/s41572-020-00243-0.","journal-title":"Nat Rev Dis Primers"},{"key":"4167_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG. Prostate cancer. Lancet. 2021;398:1075\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(21)00950-8.","journal-title":"Lancet"},{"issue":"5","key":"4167_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrurol.2009.40","volume":"6","author":"D Hessels","year":"2009","unstructured":"Hessels D, Schalken JA. The use of PCA3 in the diagnosis of prostate cancer. Nat Rev Urol. 2009;6(5):255\u201361. https:\/\/doi.org\/10.1038\/nrurol.2009.40.","journal-title":"Nat Rev Urol"},{"key":"4167_CR4","first-page":"5975","volume":"59","author":"MJ Bussemakers","year":"1999","unstructured":"Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999;59:5975\u20139.","journal-title":"Cancer Res"},{"key":"4167_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.juro.2013.02.018","volume":"190","author":"MC Gittelman","year":"2013","unstructured":"Gittelman MC, Hertzman B, Bailen J, Williams T, Koziol I, Henderson RJ, et al. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study. J Urol. 2013;190:64\u20139. https:\/\/doi.org\/10.1016\/j.juro.2013.02.018.","journal-title":"J Urol"},{"key":"4167_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1001\/jamaoncol.2024.0455","volume":"10","author":"JJ Tosoian","year":"2024","unstructured":"Tosoian JJ, Zhang Y, Xiao L, Xie C, Samora NL, Niknafs YS, et al. Development and validation of an 18-gene urine test for high-grade prostate cancer. JAMA Oncol. 2024;10:726\u201336. https:\/\/doi.org\/10.1001\/jamaoncol.2024.0455.","journal-title":"JAMA Oncol"},{"key":"4167_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","volume":"24","author":"R Shang","year":"2023","unstructured":"Shang R, Lee S, Senavirathne G, Lai EC. MicroRNAs in action: biogenesis, function and regulation. Nat Rev Genet. 2023;24:816\u201333. https:\/\/doi.org\/10.1038\/s41576-023-00611-y.","journal-title":"Nat Rev Genet"},{"key":"4167_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197040","volume":"21","author":"FDE De Palma","year":"2020","unstructured":"De Palma FDE, Luglio G, Tropeano FP, Pagano G, D\u2019Armiento M, Kroemer G, et al. The role of micro-RNAs and circulating tumor markers as predictors of response to neoadjuvant therapy in locally advanced rectal cancer. Int J Mol Sci. 2020;21:7040. https:\/\/doi.org\/10.3390\/ijms21197040.","journal-title":"Int J Mol Sci"},{"key":"4167_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102860","volume":"145","author":"J Wang","year":"2020","unstructured":"Wang J, Ni J, Beretov J, Thompson J, Graham P, Li Y. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer. Crit Rev Oncol Hematol. 2020;145:102860. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.102860.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"4167_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03326-w","volume":"23","author":"S Tang","year":"2025","unstructured":"Tang S, Cheng H, Zang X, Tian J, Ling Z, Wang L, et al. Small extracellular vesicles: crucial mediators for prostate cancer. J Nanobiotechnology. 2025;23(1):230. https:\/\/doi.org\/10.1186\/s12951-025-03326-w.","journal-title":"J Nanobiotechnology"},{"key":"4167_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41416-021-01610-8","volume":"126","author":"M Ramirez-Garrastacho","year":"2022","unstructured":"Ramirez-Garrastacho M, Bajo-Santos C, Line A, Martens-Uzunova ES, de la Fuente JM, Moros M, et al. Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research. Br J Cancer. 2022;126:331\u201350. https:\/\/doi.org\/10.1038\/s41416-021-01610-8.","journal-title":"Br J Cancer"},{"issue":"1","key":"4167_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-021-00212-w","volume":"6","author":"S Shin","year":"2021","unstructured":"Shin S, Park YH, Jung S-H, Jang S-H, Kim MY, Lee JY, et al. Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer. NPJ Genom Med. 2021;6(1):45. https:\/\/doi.org\/10.1038\/s41525-021-00212-w.","journal-title":"NPJ Genom Med"},{"issue":"1","key":"4167_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-024-01634-1","volume":"24","author":"X Luo","year":"2024","unstructured":"Luo X, Wen W. MicroRNA in prostate cancer: from biogenesis to applicative potential. BMC Urol. 2024;24(1):244. https:\/\/doi.org\/10.1186\/s12894-024-01634-1.","journal-title":"BMC Urol"},{"key":"4167_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101613","volume":"28","author":"F Ghamlouche","year":"2023","unstructured":"Ghamlouche F, Yehya A, Zeid Y, Fakhereddine H, Fawaz J, Liu Y-N, et al. MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer. Transl Oncol. 2023;28:101613. https:\/\/doi.org\/10.1016\/j.tranon.2022.101613.","journal-title":"Transl Oncol"},{"key":"4167_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206102","volume":"11","author":"A Di Minno","year":"2022","unstructured":"Di Minno A, Aveta A, Gelzo M, Tripodi L, Pandolfo SD, Crocetto F, et al. 8-hydroxy-2-deoxyguanosine and 8-iso-prostaglandin F2\u03b1: putative biomarkers to assess oxidative stress damage following robot-assisted radical prostatectomy (RARP). J Clin Med. 2022;11:6102. https:\/\/doi.org\/10.3390\/jcm11206102.","journal-title":"J Clin Med"},{"key":"4167_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.juro.2014.01.107","volume":"192","author":"I Casanova-Salas","year":"2014","unstructured":"Casanova-Salas I, Rubio-Briones J, Calatrava A, Mancarella C, Masi\u00e1 E, Casanova J, et al. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. J Urol. 2014;192:252\u20139. https:\/\/doi.org\/10.1016\/j.juro.2014.01.107.","journal-title":"J Urol"},{"key":"4167_CR17","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res [Internet]. 2013;41:D991\u20135. https:\/\/doi.org\/10.1093\/nar\/gks1193. [cited 2025 Oct 2];.","journal-title":"Nucleic Acids Res [Internet]"},{"key":"4167_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41418-024-01430-2","volume":"32","author":"FDE De Palma","year":"2025","unstructured":"De Palma FDE, Pol JG, Carbonnier V, Scuderi SA, Mannino D, Mont\u00e9gut L, et al. Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survival. Cell Death Differ. 2025;32:730\u201344. https:\/\/doi.org\/10.1038\/s41418-024-01430-2.","journal-title":"Cell Death Differ"},{"key":"4167_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77.","journal-title":"BMC Bioinformatics"},{"key":"4167_CR20","doi-asserted-by":"publisher","unstructured":"Cui S, Yu S, Huang H-Y, Lin Y-C-D, Huang Y, Zhang B et al. MiRTarBase 2025: updates to the collection of experimentally validated microRNA\u2013target interactions. Nucleic Acids Res [Internet]. 2025 [cited 2025 July 2];53:D147\u201356. https:\/\/doi.org\/10.1093\/nar\/gkae1072","DOI":"10.1093\/nar\/gkae1072"},{"key":"4167_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam J-W, Bartel DP, Izaurralde E. Predicting effective microRNA target sites in mammalian mRNAs. eLife [Internet]. 2015;4:e05005. https:\/\/doi.org\/10.7554\/eLife.05005.","journal-title":"eLife [Internet]"},{"key":"4167_CR22","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Research [Internet]. 2020;48:D127-31. https:\/\/doi.org\/10.1093\/nar\/gkz757.","journal-title":"Nucleic Acids Research [Internet]"},{"key":"4167_CR23","doi-asserted-by":"publisher","unstructured":"Skoufos G, Kakoulidis P, Tastsoglou S, Zacharopoulou E, Kotsira V, Miliotis M et al. TarBase-v9.0 extends experimentally supported miRNA\u2013gene interactions to cell-types and virally encoded miRNAs. Nucleic Acids Research [Internet]. 2024 [cited 2025 July 2];52:D304\u201310. https:\/\/doi.org\/10.1093\/nar\/gkad1071","DOI":"10.1093\/nar\/gkad1071"},{"key":"4167_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/2211-5463.12805","volume":"10","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Wen Y, Xuan C, Chen Q, Xiang Q, Wang J, et al. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis. FEBS Open Bio. 2020;10:674\u201388. https:\/\/doi.org\/10.1002\/2211-5463.12805.","journal-title":"FEBS Open Bio"},{"key":"4167_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053527","volume":"8","author":"S Shukla","year":"2013","unstructured":"Shukla S, Sharma H, Abbas A, MacLennan GT, Fu P, Danielpour D, et al. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression. PLoS One. 2013;8:e53527. https:\/\/doi.org\/10.1371\/journal.pone.0053527.","journal-title":"PLoS One"},{"key":"4167_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174156","volume":"20","author":"N Glatzel-Pluci\u0144ska","year":"2019","unstructured":"Glatzel-Pluci\u0144ska N, Piotrowska A, Dzi\u0119giel P, Podhorska-Oko\u0142\u00f3w M. The role of SATB1 in tumour progression and metastasis. Int J Mol Sci. 2019;20:4156. https:\/\/doi.org\/10.3390\/ijms20174156.","journal-title":"Int J Mol Sci"},{"key":"4167_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612986","volume":"24","author":"GS Krasnov","year":"2023","unstructured":"Krasnov GS, Puzanov GA, Dashinimaev EB, Vishnyakova KS, Kondratieva TT, Chegodaev YS, et al. Tumor suppressor properties of small C-terminal domain phosphatases in clear cell renal cell carcinoma. Int J Mol Sci. 2023;24:12986. https:\/\/doi.org\/10.3390\/ijms241612986.","journal-title":"Int J Mol Sci"},{"key":"4167_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11113-9","volume":"23","author":"Z Wang","year":"2023","unstructured":"Wang Z, Guan W, Ma Y, Zhou X, Song G, Wei J, et al. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt\/\u03b2-catenin signaling pathway. BMC Cancer. 2023;23:668. https:\/\/doi.org\/10.1186\/s12885-023-11113-9.","journal-title":"BMC Cancer"},{"key":"4167_CR29","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2023.2712","volume":"20","author":"S Takamizawa","year":"2024","unstructured":"Takamizawa S, Kojima J, Umezu T, Kuroda M, Hayashi S, Maruta T, et al. miR\u2011146a\u20115p and miR\u2011191\u20115p as novel diagnostic marker candidates for ovarian clear cell carcinoma. Mol Clin Oncol. 2024;20:14. https:\/\/doi.org\/10.3892\/mco.2023.2712.","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"4167_CR30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3892\/etm.2019.7668","volume":"18","author":"F Li","year":"2019","unstructured":"Li F, Wen J, Shi J, Wang Y, Yang F, Liu C. MicroRNA\u2011191 targets CCAAT\/enhanced binding protein \u03b2 and functions as an oncogenic molecule in human non\u2011small cell lung carcinoma cells. Exp Ther Med. 2019;18(2):1175\u201383. https:\/\/doi.org\/10.3892\/etm.2019.7668.","journal-title":"Exp Ther Med"},{"key":"4167_CR31","unstructured":"Wu H-Y, Li M-W, Li Q-Q, Pang Y-Y, Chen G, Lu H-P et al. Elevation of miR-191-5p level and its potential signaling pathways in hepatocellular carcinoma: a study validated by microarray and in-house qRT-PCR with 1,291 clinical samples. Int J Clin Exp Pathol [Internet]. 2019 [cited 2025 June 20];12:1439\u201356. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6947072\/. Accessed 20 June 2025."},{"key":"4167_CR32","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10494","volume":"8","author":"Y Ashirbekov","year":"2020","unstructured":"Ashirbekov Y, Abaildayev A, Omarbayeva N, Botbayev D, Belkozhayev A, Askandirova A, et al. Combination of circulating miR-145-5p\/miR-191-5p as biomarker for breast cancer detection. PeerJ. 2020;8:e10494. https:\/\/doi.org\/10.7717\/peerj.10494.","journal-title":"PeerJ"},{"key":"4167_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118330","volume":"189","author":"F Porcel-Pastrana","year":"2025","unstructured":"Porcel-Pastrana F, Montero-Hidalgo AJ, Herrero-Aguayo V, S\u00e1ez-Mart\u00ednez P, Perez-G\u00f3mez JM, Sarmento-Cabral A, et al. miR-191-5p: a tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity. Biomed Pharmacother. 2025;189:118330. https:\/\/doi.org\/10.1016\/j.biopha.2025.118330.","journal-title":"Biomed Pharmacother"},{"key":"4167_CR34","first-page":"444","volume":"23","author":"X Wang","year":"2018","unstructured":"Wang X, Shi Z, Liu X, Su Y, Li W, Dong H, et al. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer. J BUON. 2018;23:444\u201352.","journal-title":"J BUON"},{"key":"4167_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016193","volume":"98","author":"J Liu","year":"2019","unstructured":"Liu J, Yan Y, Shi J, Wu Y, Li Y, Dai L, et al. Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer. Medicine. 2019;98:e16193. https:\/\/doi.org\/10.1097\/MD.0000000000016193.","journal-title":"Medicine"},{"key":"4167_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2019.12.025","volume":"473","author":"J Ray","year":"2020","unstructured":"Ray J, Haughey C, Hoey C, Jeon J, Murphy R, Dura-Perez L, et al. miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA. Cancer Lett. 2020;473:107\u201317. https:\/\/doi.org\/10.1016\/j.canlet.2019.12.025.","journal-title":"Cancer Lett"},{"key":"4167_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016193","volume":"98","author":"J Liu","year":"2019","unstructured":"Liu J, Yan Y, Shi J, Wu Y, Li Y, Dai L, et al. Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer. Medicine. 2019;98:e16193. https:\/\/doi.org\/10.1097\/MD.0000000000016193.","journal-title":"Medicine"},{"key":"4167_CR38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s10388-025-01116-9","volume":"22","author":"H Wang","year":"2025","unstructured":"Wang H, Matsumoto Y, Maiyulan A, Toyozumi T, Otsuka R, Sekino N, et al. Circulating exosome-derived miR-191-5p is a novel therapeutic biomarker for radiotherapy in esophageal squamous cell carcinoma patients. Esophagus. 2025;22:454\u201366. https:\/\/doi.org\/10.1007\/s10388-025-01116-9.","journal-title":"Esophagus"},{"key":"4167_CR39","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193094","volume":"39","author":"GS Krasnov","year":"2019","unstructured":"Krasnov GS, Puzanov GA, Afanasyeva MA, Dashinimaev EB, Vishnyakova KS, Beniaminov AD, et al. Tumor suppressor properties of the small C-terminal domain phosphatases in non-small cell lung cancer. Biosci Rep. 2019;39:BSR20193094. https:\/\/doi.org\/10.1042\/BSR20193094.","journal-title":"Biosci Rep"},{"key":"4167_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1535929","volume":"15","author":"J Bai","year":"2025","unstructured":"Bai J, Yang G, Yu Q, Chi Q, Zeng X, Qi W. SATB1 in cancer progression and metastasis: mechanisms and therapeutic potential. Front Oncol. 2025;15:1535929. https:\/\/doi.org\/10.3389\/fonc.2025.1535929.","journal-title":"Front Oncol"},{"key":"4167_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-111","volume":"11","author":"L Mao","year":"2013","unstructured":"Mao L, Yang C, Wang J, Li W, Wen R, Chen J, et al. SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion. J Transl Med. 2013;11:111. https:\/\/doi.org\/10.1186\/1479-5876-11-111.","journal-title":"J Transl Med"},{"key":"4167_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/odi.12602","volume":"23","author":"Y-C Li","year":"2017","unstructured":"Li Y-C, Bu L-L, Mao L, Ma S-R, Liu J-F, Yu G-T, et al. SATB1 promotes tumor metastasis and invasiveness in oral squamous cell carcinoma. Oral Dis. 2017;23:247\u201354. https:\/\/doi.org\/10.1111\/odi.12602.","journal-title":"Oral Dis"},{"key":"4167_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03702-0","volume":"11","author":"C Dumke","year":"2021","unstructured":"Dumke C, Gemoll T, Oberl\u00e4nder M, Freitag-Wolf S, Thorns C, Glaessgen A, et al. SATB1, genomic instability and Gleason grading constitute a novel risk score for prostate cancer. Sci Rep. 2021;11:24446. https:\/\/doi.org\/10.1038\/s41598-021-03702-0.","journal-title":"Sci Rep"},{"key":"4167_CR44","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.3892\/ol.2017.5765","volume":"13","author":"H Qi","year":"2017","unstructured":"Qi H, Fu X, Li Y, Pang X, Chen S, Zhu X, et al. SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer. Oncol Lett. 2017;13:2577\u201382. https:\/\/doi.org\/10.3892\/ol.2017.5765.","journal-title":"Oncol Lett"},{"key":"4167_CR45","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40:e108647. https:\/\/doi.org\/10.15252\/embj.2021108647.","journal-title":"EMBO J"},{"key":"4167_CR46","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/carcin\/bgt107","volume":"34","author":"N Nagpal","year":"2013","unstructured":"Nagpal N, Ahmad HM, Molparia B, Kulshreshtha R. Microrna-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis. 2013;34:1889\u201399. https:\/\/doi.org\/10.1093\/carcin\/bgt107.","journal-title":"Carcinogenesis"},{"key":"4167_CR47","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.bbrc.2012.05.153","volume":"423","author":"AM Lena","year":"2012","unstructured":"Lena AM, Mancini M, Rivetti di Val Cervo P, Saintigny G, Mah\u00e9 C, Melino G, et al. MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation. Biochem Biophys Res Commun [Internet]. 2012;423:1763\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2012.05.153. [cited 2025 June 20];.","journal-title":"Biochem Biophys Res Commun [Internet]"},{"key":"4167_CR48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10753-023-01925-z","volume":"47","author":"K-Q Yu","year":"2024","unstructured":"Yu K-Q, Li C-F, Ye L, Song Y, Wang Y-H, Lin Y-R, et al. Long non-coding RNA ANRIL regulates inflammatory factor expression in ulcerative colitis via the miR-191-5p\/SATB1 axis. Inflammation. 2024;47:513\u201329. https:\/\/doi.org\/10.1007\/s10753-023-01925-z.","journal-title":"Inflammation"},{"key":"4167_CR49","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","volume":"18","author":"M Ignatiadis","year":"2021","unstructured":"Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic \u2014 implementation issues and future challenges. Nat Rev Clin Oncol. 2021;18:297\u2013312. https:\/\/doi.org\/10.1038\/s41571-020-00457-x.","journal-title":"Nat Rev Clin Oncol"},{"key":"4167_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101198","volume":"4","author":"SM Batool","year":"2023","unstructured":"Batool SM, Yekula A, Khanna P, Hsia T, Gamblin AS, Ekanayake E, et al. The liquid biopsy consortium: challenges and opportunities for early cancer detection and monitoring. Cell Reports Medicine. 2023;4:101198. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101198.","journal-title":"Cell Reports Medicine"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04167-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:02:59Z","timestamp":1770984179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04167-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4167"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04167-9","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of University of Naples (protocol number 253\/2023 of 05\/06\/2023, Naples, Italy) and was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}